Review on Various Analytical and Bioanalytical Methodologies for Fluconazole
International Journal of Development Research
Review on Various Analytical and Bioanalytical Methodologies for Fluconazole
Received 29th January, 2025; Received in revised form 17th February, 2025; Accepted 19th March, 2025; Published online 28th April, 2025
Copyright©2025, Ritika Shrivastava et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fluconazole is an azole antifungal drug, used to treat serious fungal or yeast infections, such as those affecting the vagina, mouth or throat, lungs, bladder, or blood. It comes in injectable, topical and oral dosageforms. The development and validation of analytical methods are ongoing, interrelated processes carried out during the drug development process. Establishing the suggested analytical method's accuracy, specificity, precision, and robustness for the pharmaceutical industry's analysis of a drug moiety is the main goal of its development and validation. The creation of a methodology is necessary for the pharmaceutical formulation's drug discovery, development, and assessment. Validation is required to demonstrate that an analytical method is appropriate and suitable for the intended use, which is frequently a crucial prerequisite for analytical purposes. This article focuses on the development of different analytical method development techniques and validation of fluconazole.